An open-label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer

Title
An open-label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer
Authors
Keywords
-
Journal
CANCER
Volume 118, Issue 17, Pages 4098-4104
Publisher
Wiley
Online
2012-01-27
DOI
10.1002/cncr.26730

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search